Actinium Pharmaceuticals Stock Forecast - Daily Balance Of Power

ATNM Stock  USD 1.25  0.03  2.34%   
Actinium Stock Forecast is based on your current time horizon. Although Actinium Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Actinium Pharmaceuticals' systematic risk associated with finding meaningful patterns of Actinium Pharmaceuticals fundamentals over time.
  
As of the 13th of December 2024, Payables Turnover is likely to drop to 0.04. In addition to that, Fixed Asset Turnover is likely to drop to 0.03. As of the 13th of December 2024, Common Stock Shares Outstanding is likely to grow to about 27.9 M, while Net Loss is likely to drop (31.2 M).
On December 6, 2024 Actinium Pharmaceuticals had Daily Balance Of Power of 0.6667. Balance of Power indicator (or BOP) measures the strength of Actinium Pharmaceuticals market sensitivity to bulls and bears. It estimates the ability of Actinium Pharmaceuticals buyers and sellers to push price to an extreme high or extreme low level. As a result, by monitoring Actinium Pharmaceuticals Balance of Power indicator one can determine a trend of the price direction.
Check Actinium Pharmaceuticals VolatilityBacktest Actinium PharmaceuticalsTrend Details  

Actinium Pharmaceuticals Trading Date Momentum

On December 09 2024 Actinium Pharmaceuticals was traded for  1.32  at the closing time. The top price for the day was 1.40  and the lowest listed price was  1.31 . The trading volume for the day was 368.3 K. The trading history from December 9, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 2.94% . The overall trading delta against the current closing price is 4.41% .
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare Actinium Pharmaceuticals to competition

Other Forecasting Options for Actinium Pharmaceuticals

For every potential investor in Actinium, whether a beginner or expert, Actinium Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Actinium Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Actinium. Basic forecasting techniques help filter out the noise by identifying Actinium Pharmaceuticals' price trends.

View Actinium Pharmaceuticals Related Equities

 Risk & Return  Correlation

Actinium Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Actinium Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Actinium Pharmaceuticals' current price.

Actinium Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Actinium Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Actinium Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Actinium Pharmaceuticals stock market strength indicators, traders can identify Actinium Pharmaceuticals entry and exit signals to maximize returns.

Actinium Pharmaceuticals Risk Indicators

The analysis of Actinium Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Actinium Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting actinium stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Actinium Pharmaceuticals is a strong investment it is important to analyze Actinium Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Actinium Pharmaceuticals' future performance. For an informed investment choice regarding Actinium Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Actinium Pharmaceuticals to cross-verify your projections.
To learn how to invest in Actinium Stock, please use our How to Invest in Actinium Pharmaceuticals guide.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Actinium Pharmaceuticals. If investors know Actinium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Actinium Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.36)
Revenue Per Share
0.003
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.31)
Return On Equity
(0.88)
The market value of Actinium Pharmaceuticals is measured differently than its book value, which is the value of Actinium that is recorded on the company's balance sheet. Investors also form their own opinion of Actinium Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Actinium Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Actinium Pharmaceuticals' market value can be influenced by many factors that don't directly affect Actinium Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Actinium Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Actinium Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Actinium Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.